MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS
The invention provides non-naturally occurring microbial organisms having a 4-hydroxybutyrate, gamma-butyrolactone, 1,4-butanediol, 4-hydroxybutanal, 4-hydroxybutyryl-CoA and/or putrescine pathway and being capable of producing 4-hydroxybutyrate, wherein the microbial organism comprises one or more genetic modifications. The invention additionally provides methods of producing 4-hydroxybutyrate, gamma-butyrolactone, 1,4-butanediol, 4-hydroxybutanal, 4-hydroxybutyryl-CoA and/or putrescine or related products using the microbial organisms.
1 .- 56 . (canceled)
57 . An isolated polypeptide comprising an amino acid sequence referenced in Tables 53, 55 or 57, wherein said amino acid sequence comprises one or more variant amino acid positions set forth in Tables 54, 56 or 58 or Example XXXXIII.
58 . The isolated polypeptide of claim 57 , wherein said amino acid sequence other than said one or more variant amino acid positions has at least 65%, 70%, 75%, 80%, 85%, 90%, 95%, 98% or 99% sequence identity, or is identical, to an amino acids sequence referenced in Tables 53, 55 or 57, with the proviso that the amino acid sequence is not the wild type parental sequence or a naturally occurring amino acid sequence.
59 . The isolated polypeptide of claim 58 , wherein said amino acid sequence comprises two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen, sixteen, seventeen, eighteen, nineteen, twenty or more variant amino acid positions set forth in Tables 54, 56 or 58 or Example XXXXIII.
60 . The isolated polypeptide of claim 59 , wherein said amino acid sequence further comprises a conservative amino acid substitution in from 1 to 100 amino acid positions, wherein said positions are other than the variant amino acid positions set forth in Tables 54, 56 or 58 or Example XXXXIII.
61 . The isolated polypeptide of claim 57 , wherein said amino acid sequence comprises no modification at from 2 to 300 amino acid positions compared to the parent sequence, wherein said positions are selected from those that are identical to between 2, 3, 4, or 5 of the amino acid sequences referenced in Tables 53, 55 or 57.
62 . The isolated polypeptide of claim 57 , wherein said polypeptide can convert 4-hydroxybutyrate to 4-hydroxybutyryl-CoA, 4-hydroxybutyryl-CoA to 4-hydroxybutyraldehyde, or 4-hydroxybutyraldehyde to 1,4-butanediol.
63 . A host cell expressing the polypeptide of claim 57 .
64 . Use of the polypeptide of claim 57 as a biocatalyst.
65 . A composition comprising the polypeptide of claim 57 and at least one substrate for said polypeptide.
66 . The composition of claim 65 , wherein said polypeptide can react with said substrate under in vitro conditions.
67 . A method for producing 4-hydroxybutyrate (4-HB), gamma-butyrolactone (GBL), 4-hydroxybutyraldehyde (4-HBal), 4-hydroxybutyryl-CoA (4-HBCoA), 1,4-butanediol (BDO) and/or putrescine comprising culturing said host cell of claim 63 under conditions and for a sufficient period of time to produce 4-HB, GBL, 4-HBal, 4-HBCoA, BDO and/or putrescine.
68 . The method of claim 67 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium.
69 . A method for producing 4-HB, GBL, 4-HBal, 4-HBCoA, BDO and/or putrescine, comprising culturing a non-naturally occurring microbial organism having a pathway that produces 4-HB, GBL, 4-HBal, 4-HBCoA, BDO and/or putrescine under conditions and for a sufficient period of time to produce 4-HB, GBL, 4-HBal, 4-HBCoA, BDO and/or putrescine, wherein said microbial organism comprises the polypeptide of claim 57 .
70 . The method of claim 69 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium.